Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7056492, 11 pages
http://dx.doi.org/10.1155/2016/7056492
Clinical Study

Bioartificial Therapy of Sepsis: Changes of Norepinephrine-Dosage in Patients and Influence on Dynamic and Cell Based Liver Tests during Extracorporeal Treatments

1Departments of Anesthesiology and Intensive Care Medicine, Medical Faculty of the University of Rostock, 18057 Rostock, Germany
2Departments of Medicine, Division of Nephrology, Medical Faculty of the University of Rostock, 18057 Rostock, Germany
3Departments of Surgery, Medical Faculty of the University of Rostock, 18057 Rostock, Germany
4Fraunhofer Institute for Cell Therapy and Immunology, 04103 Leipzig, Germany

Received 21 February 2016; Accepted 2 June 2016

Academic Editor: Zsolt Molnar

Copyright © 2016 Martin Sauer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Engel, F. M. Brunkhorst, H.-G. Bone et al., “Epidemiology of sepsis in Germany: results from a national prospective multicenter study,” Intensive Care Medicine, vol. 33, no. 4, pp. 606–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Schmid, H. Burchardi, J. Clouth, and H. Schneider, “Burden of illness imposed by severe sepsis in Germany,” European Journal of Health Economics, vol. 3, no. 2, pp. 77–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Lee, C. J. Doig, W. A. Ghali, C. Donaldson, D. Johnson, and B. Manns, “Detailed cost analysis of care for survivors of severe sepsis,” Critical Care Medicine, vol. 32, no. 4, pp. 981–985, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Takala, “Should we target blood pressure in sepsis?” Critical Care Medicine, vol. 38, no. 10, pp. S613–S619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Kramer, B. Jordan, W. Druml, P. Bauer, and P. G. H. Metnitz, “Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study,” Critical Care Medicine, vol. 35, no. 4, pp. 1099–1104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Bakker, R. Grover, A. McLuckie et al., “Administration of the nitric oxide synthase inhibitor NG-methyl- L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study,” Critical Care Medicine, vol. 32, no. 1, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Rimmelé and J. A. Kellum, “Clinical review: blood purification for sepsis,” Critical Care, vol. 15, no. 1, article 205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Shukla, “Extracorporeal therapy in sepsis: are we there yet,” Kidney International, vol. 81, no. 4, pp. 336–338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Ellis, R. D. Hughes, J. A. Wendon et al., “Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure,” Hepatology, vol. 24, no. 6, pp. 1446–1451, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. I. M. Sauer, K. Zeilinger, N. Obermayer et al., “Primary human liver cells as source for modular extracoporeal liver support-a preliminary report,” International Journal of Artificial Organs, vol. 25, no. 10, pp. 1001–1005, 2002. View at Google Scholar · View at Scopus
  12. H. D. Humes, D. A. Buffington, L. Lou et al., “Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock,” Critical Care Medicine, vol. 31, no. 10, pp. 2421–2428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. H. D. Humes, W. F. Weitzel, R. H. Bartlett, F. C. Swaniker, and E. P. Paganini, “Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure,” Blood Purification, vol. 21, no. 1, pp. 64–71, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Tumlin, R. Wali, W. Williams et al., “Efficacy and safety of renal tubule cell therapy for acute renal failure,” Journal of the American Society of Nephrology, vol. 19, no. 5, pp. 1034–1040, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. R. Mitzner, J. Freytag, M. Sauer et al., “Use of human preconditioned phagocytes for extracorporeal immune support: introduction of a concept,” Therapeutic Apheresis, vol. 5, no. 5, pp. 423–432, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Caille, J.-D. Chiche, N. Nciri et al., “Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock,” Shock, vol. 22, no. 6, pp. 521–526, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Kaufmann, A. Hoelzl, F. Schliephake et al., “Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity,” Shock, vol. 26, no. 3, pp. 254–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Pachot, G. Monneret, A. Brion et al., “Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients,” Critical Care Medicine, vol. 33, no. 1, pp. 31–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. M. Tavares-Murta, M. Zaparoli, R. B. Ferreira et al., “Failure of neutrophil chemotactic function in septic patients,” Critical Care Medicine, vol. 30, no. 5, pp. 1056–1061, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Keel, U. Ungethüm, U. Steckholzer et al., “Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis,” Blood, vol. 90, no. 9, pp. 3356–3363, 1997. View at Google Scholar · View at Scopus
  21. G. Egger, R. Aigner, A. Glasner, H. P. Hofer, H. Mitterhammer, and S. Zelzer, “Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters,” Intensive Care Medicine, vol. 30, no. 2, pp. 331–334, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Lehmann, U. Novender, S. Schroeder et al., “Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis,” Intensive Care Medicine, vol. 27, no. 8, pp. 1412–1415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Wenisch, P. Parschalk, M. Hasenhündl, A. Griesmacher, and W. Graninger, “Polymorphonuclear leucocyte dysregulation in patients with gram-negative septicaemia assessed by flow cytometry,” European Journal of Clinical Investigation, vol. 25, no. 6, pp. 418–424, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sauer, J. Altrichter, H. J. Kreutzer et al., “Extracorporeal cell therapy with granulocytes in a pig model of Gram-positive sepsis,” Critical Care Medicine, vol. 37, no. 2, pp. 606–613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Altrichter, M. Sauer, K. Kaftan et al., “Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study,” Critical Care, vol. 15, no. 2, article R82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sauer, J. Altrichter, H.-J. Kreutzer et al., “Safety evaluation for a cell-based immune support system in an ex vivo rat model of gram-negative sepsis,” Therapeutic Apheresis and Dialysis, vol. 13, no. 5, pp. 444–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Liton and M. Morgan, “The PiCCO monitor: a review,” Anaesthesia and Intensive Care, vol. 40, no. 3, pp. 393–409, 2012. View at Google Scholar · View at Scopus
  28. S. G. Sakka, “Assessing liver function,” Current Opinion in Critical Care, vol. 13, no. 2, pp. 207–214, 2007. View at Publisher · View at Google Scholar
  29. M. Sauer, “The use of human hepatocytes to determine liver function and liver regeneration,” PCT/EP 2007/001047; DE/2006 102006005526.
  30. M. Sauer, C. Haubner, T. Mencke et al., “Impaired cell functions of hepatocytes incubated with plasma of septic patients,” Inflammation Research, vol. 61, no. 6, pp. 609–616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. “American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, pp. 864–874, 1992.
  32. G. R. Bernard, J.-L. Vincent, P.-F. Laterre et al., “Efficacy and safety of recombinant human activated protein C for severe sepsis,” New England Journal of Medicine, vol. 344, no. 10, pp. 699–709, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. D. A. Scudiero, R. H. Shoemaker, K. D. Paull et al., “Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines,” Cancer Research, vol. 48, no. 17, pp. 4827–4833, 1988. View at Google Scholar · View at Scopus
  34. J. H. Kelly and N. L. Sussman, “A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibition,” Journal of Biomolecular Screening, vol. 5, no. 4, pp. 249–253, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. K. G. Kreymann, G. de Heer, A. Nierhaus, and S. Kluge, “Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock,” Critical Care Medicine, vol. 35, no. 12, pp. 2677–2685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. P.-Y. Bochud and T. Calandra, “Science, medicine, and the future: pathogenesis of sepsis: new concepts and implications for future treatment,” British Medical Journal, vol. 326, no. 7383, pp. 262–266, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. S. A. Nasraway, “The problems and challenges of immunotherapy in sepsis,” Chest, vol. 123, no. 5, pp. 451–459, 2003. View at Google Scholar · View at Scopus
  38. C. Ronco, P. Inguaggiato, V. D'Intini et al., “The role of extracorporeal therapies in sepsis,” Journal of Nephrology, vol. 16, supplement 7, pp. S34–S41, 2003. View at Google Scholar · View at Scopus
  39. R. Bellomo, P. Honoré, J. Matson, C. Ronco, and J. Winchester, “Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis,” International Journal of Artificial Organs, vol. 28, no. 5, pp. 450–458, 2005. View at Google Scholar · View at Scopus
  40. J. S. Boomer, K. To, K. C. Chang et al., “Immunosuppression in patients who die of sepsis and multiple organ failure,” The Journal of the American Medical Association, vol. 306, no. 23, pp. 2594–2605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Mohan and P. Brocklehurst, “Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia,” Cochrane Database of Systematic Reviews, vol. 4, Article ID CD003956, 2004. View at Publisher · View at Google Scholar
  42. S. J. Stanworth, E. Massey, C. Hyde et al., “Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD005339, 2005. View at Google Scholar · View at Scopus
  43. A. Safdar, H. A. Hanna, M. Boktour et al., “Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of candida species bloodstream infections,” Cancer, vol. 101, no. 12, pp. 2859–2865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. W. Dünser, E. Ruokonen, V. Pettilä et al., “Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial,” Critical Care, vol. 13, no. 6, article R181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. C. M. Pastor and P. M. Suter, “Hepatic hemodynamics and cell functions in human and experimental sepsis,” Anesthesia and Analgesia, vol. 89, no. 2, pp. 344–352, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Moreno, J.-L. Vincent, R. Matos et al., “The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study,” Intensive Care Medicine, vol. 25, no. 7, pp. 686–696, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Kimura, T. Yoshioka, M. Shibuya, T. Sakano, R. Tanaka, and S. Matsuyama, “Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival,” Critical Care Medicine, vol. 29, no. 6, pp. 1159–1163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. S. G. Sakka, K. Reinhart, and A. Meier-Hellmann, “Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients,” Chest, vol. 122, no. 5, pp. 1715–1720, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Weis, E. Kilger, A. Beiras-Fernandez et al., “Indocyanine green clearance as an outcome prediction tool in cardiac surgery: a prospective study,” Journal of Critical Care, vol. 29, no. 2, pp. 224–229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Zoller, K. Spanaus, R. Gerster et al., “ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients—a prospective study of accuracy for prediction of length of stay in the ICU,” Annals of Intensive Care, vol. 4, article 19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Stehr, F. Ploner, K. Traeger et al., “Plasma disappearance of indocyanine green: a marker for excretory liver function?” Intensive Care Medicine, vol. 31, no. 12, pp. 1719–1722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. B. M. Halle, T. D. Poulsen, and H. P. Pedersen, “Indocyanine green plasma disappearance rate as dynamic liver function test in critically ill patients,” Acta Anaesthesiologica Scandinavica, vol. 58, no. 10, pp. 1214–1219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Regueira, P. M. Lepper, S. Brandt et al., “Hypoxia inducible factor-1α induction by tumour necrosis factor-α, but not by toll-like receptor agonists, modulates cellular respiration in cultured human hepatocytes,” Liver International, vol. 29, no. 10, pp. 1582–1592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. A. El-Saadany, H. M. Rawel, J. Raila, M. S. El-Dashloty, and F. J. Schweigert, “Antioxidants modulate the IL-6 induced inhibition of negative acute-phase protein secretion in HepG2 cells,” Cell Biochemistry and Function, vol. 26, no. 1, pp. 95–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Nakai, H. Tanaka, K. Hanada et al., “Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients,” Drug Metabolism & Disposition, vol. 36, no. 9, pp. 1786–1793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Li, A. Jahan, and J. Y. L. Chiang, “Bile acids and cytokines inhibit the human cholesterol 7α-hydroxylase gene via the JNK/c-Jun pathway in human liver cells,” Hepatology, vol. 43, no. 6, pp. 1202–1210, 2006. View at Publisher · View at Google Scholar · View at Scopus